Name: Axsome Therapeutics, Inc. (AXSM) — quotes and trading statistics
Creator: TradeAlmanac
License: https://tradealmanac.com/en/sources

Loading the list…

Multiples: Axsome Therapeutics, Inc. (AXSM) — TradeAlmanac

Company valuation

Based on the last 12 months of reports, through 30 June 2026

The sector median covers every company in the sector on the US market, loss-making ones included.

How to read the figures

Market capitalization is the value of all of a company's shares at the current price: the price of one share times the number of shares.
Enterprise value (EV) is market capitalization plus debt minus cash: what the whole business, with its obligations, would cost to buy.
P/S (price / sales) is market capitalization divided by revenue over 12 months: what the market pays for each unit of sales. Useful when there is no profit yet.
P/B (price / book) is market capitalization divided by shareholders' equity: below one means the market values the company under its accounting assets net of debt.
ROE (return on equity) is net income over 12 months divided by shareholders' equity: how much profit the company earns on each unit of its owners' capital.
ROA (return on assets) is net income divided by total assets: how efficiently the company uses what it owns.
Net margin is the share of net income in revenue: how much profit remains from each unit of sales.
Operating margin is the share of profit from core operations in revenue, before interest and taxes.
Debt / equity compares borrowed money with shareholders' equity: the higher it is, the more the company depends on lenders.
The current ratio is current assets divided by short-term liabilities: whether the company has enough cash and inventory to pay its nearest debts.
Revenue growth is the change in revenue over the last 12 months against the same period a year earlier.

Axsome Therapeutics, Inc. (AXSM)